Feasibility Study


The purpose of the feasibility study is to test the new patient-led follow-up method for low risk head and neck cancer patients in a small number of patients before testing in a larger clinical study.

Number of participants

30 patients and their recruiting clinicians.

Eligibility criteria

  • Head and neck cancer patients, at around 1 year after finishing treatment
  • Aged 18 years or older
  • Written informed consent by the patients.

Study Schema

Feasibility Schema.svg

Feasibility Study Overview

Chief Investigator: Dr Paul Nankivell
Status: Open
CPMS ID: 50360
Open to new sites? Yes
First SIV: 17th January 2022
First patient recruited: 20th May 2022
Anticipated recruitment end date: August 2022
Contact details: PETNECK2@trials.bham.ac.uk

More information for healthcare professionals - please click here